Advertisement

Pleomorphic Adenoma

  • Joaquín J. García
Chapter

Abstract

Pleomorphic adenoma is the benign counterpart of carcinoma ex pleomorphic adenoma. Pleomorphic adenoma affects children and adults and presents at a mean age of approximately 45 years. Women are involved more than men. The majority of cases involve the parotid gland, presenting as single or multiple masses. Pleomorphic adenoma may be well-circumscribed or multinodular, comprised of multiple cell types (ductal, myoepithelial, and chondromyxoid stromal), and exhibit a variety of architectural patterns (solid, cystic, and cartilaginous) (Figs. 22.1, 22.2, 22.3, 22.4, 22.5, 22.6, 22.7, 22.8, 22.9, 22.10, 22.11, 22.12, 22.13, 22.14, 22.15, 22.16, 22.17, 22.18, 22.19, 22.20, 22.21, 22.22, 22.23, 22.24, 22.25, 22.26, 22.28, 22.29, 22.30, 22.31, 22.32, 22.33, 22.34, 22.35 and 22.36).

Keywords

Mixed tumor Benign mixed tumor 

Suggested Reading

  1. Baldi A, Persichetti P, Di Marino MP, Nicoletti G, Baldi F. Pleomorphic adenoma of cervical heterotopic salivary glands. J Exp Clin Cancer Res. 2003;22(4):645–7.PubMedGoogle Scholar
  2. Blevins NH, Jackler RK, Kaplan MJ, Boles R. Facial paralysis due to benign parotid tumors. Arch Otolaryngol Head Neck Surg. 1992;118:427–30.CrossRefGoogle Scholar
  3. Colella G, Cannavale R, Chiodini P. Meta-analysis of surgical approaches to the treatment of parotid pleomorphic adenomas and recurrence rates. J Craniomaxillofac Surg. 2015;43:738–45.CrossRefGoogle Scholar
  4. Coombes DM, Kaddour R, Shah N. Synchronous unilateral pleomorphic adenomas in the parotid gland: report of a case. Br J Oral Maxillofac Surg. 2009;47:155–6.CrossRefGoogle Scholar
  5. Eveson JW, Cawson RA. Salivary gland tumors. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146:51–8.CrossRefGoogle Scholar
  6. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28:279–328.PubMedGoogle Scholar
  7. Gnepp DR, Schroeder W, Heffner D. Synchronous tumors arising in a single major salivary gland cancer. Cancer. 1989;63:1219–24.CrossRefGoogle Scholar
  8. Guntinas-Lichius O, Kick C, Klussmann JP, Jungehuelsing M, Stennert E. Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. Eur Arch Otorhinolaryngol. 2004;261(3):143–6.CrossRefGoogle Scholar
  9. Huang JT, Li W, Chen XQ, Shi RH, Zhao YF. Synchronous bilateral pleomorphic adenomas of the parotid gland. J Investig Clin Dent. 2012;3:225–7.CrossRefGoogle Scholar
  10. Knight J, Ratnasingham K. Metastasizing pleomorphic adenoma: systematic review. Int J Surg. 2015;19:137–45.CrossRefGoogle Scholar
  11. Lam PW, Chan JK, Sin VC. Nasal pleomorphic adenoma with skeletal muscle differentiation: potential misdiagnosis as rhabdomyosarcoma. Hum Pathol. 1997;28(11):1299–302.CrossRefGoogle Scholar
  12. Manucha V, Ioffe OB. Metastasizing pleomorphic adenoma of the salivary gland. Arch Pathol Lab Med. 2008;132:1445–7.PubMedGoogle Scholar
  13. Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch. 2011;458(5):583–92.CrossRefGoogle Scholar
  14. Miliauskas JR, Hunt JL. Primary unilateral multifocal pleomorphic adenoma of the parotid gland: molecular assessment and literature review. Head Neck Pathol. 2008;2:339–42.CrossRefGoogle Scholar
  15. Narozny W, Kuczkowski J, Mikaszewski B. Pleomorphic adenoma of the nasal cavity: clinical analysis of 8 cases. Am J Otolaryngol. 2005;26(3):218.CrossRefGoogle Scholar
  16. Perumal CJ, Meyer M, Mohamed A. A giant pleomorphic adenoma of the submandibular salivary gland: a case report. Craniomaxillofac Trauma Reconstr. 2012;5:185–8.CrossRefGoogle Scholar
  17. Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol. 1995;104(2):100–4.CrossRefGoogle Scholar
  18. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;20:834–40.CrossRefGoogle Scholar
  19. Riad MA, Abdel-Rahman H, Ezzat WF, Adly A, Dessouky O, Shehata M. Variables related to recurrence of pleomorphic adenomas: outcome of parotid surgery in 182 cases. Laryngoscope. 2011;121:1467–72.CrossRefGoogle Scholar
  20. Sataloff RT, Price DB, Roberts BR. Bilateral synchronous mixed tumors of the parotid glands. Arch Otolaryngol Head Neck Surg. 1987;113:880–1.CrossRefGoogle Scholar
  21. Skalova A, Altemani A, Di Palma S, Simpson RH, Hosticka L, Andrle P, et al. Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall. Am J Surg Pathol. 2012;36:1674–82.CrossRefGoogle Scholar
  22. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8:177–84.CrossRefGoogle Scholar
  23. Triantafyllou A, Thompson LD, Devaney KO, Bell D, Hunt JL, Rinaldo A, et al. Functional histology of salivary gland Pleomophic adenoma: an appraisal. Head Neck Pathol. 2015;9:387–404.CrossRefGoogle Scholar
  24. Wittekindt C, Streubel K, Arnold G, Stennert E, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck. 2007;29:822–8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Joaquín J. García
    • 1
  1. 1.Mayo Clinic School of Medicine, Department of Laboratory Medicine & PathologyMayo Clinic RochesterRochesterUSA

Personalised recommendations